• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.在混合淋巴细胞反应期间,树突状细胞对同种抗原特异性Foxp3 + CD25 + CD4 +调节性T细胞的有效扩增。
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2758-63. doi: 10.1073/pnas.0510606103. Epub 2006 Feb 10.
2
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.树突状细胞可扩增抗原特异性的Foxp3⁺CD25⁺CD4⁺调节性T细胞,包括同种异体反应性抑制细胞。
Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x.
3
Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.TGF-β1 和 IL-2 共刺激的树突状细胞将初始 CD4+ T 细胞分化为同种抗原特异性和移植物保护性的 Foxp3+调节性 T 细胞。
Transplantation. 2012 Mar 27;93(6):580-8. doi: 10.1097/TP.0b013e318244dd67.
4
Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.非淋巴细胞减少宿主中同种异体抗原诱导的CD4 + CD25 + Foxp3 +调节性T细胞对慢性移植物抗宿主病的阻断作用。
J Leukoc Biol. 2007 Nov;82(5):1053-61. doi: 10.1189/jlb.0407227. Epub 2007 Aug 7.
5
Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.树突状细胞与抗 CD3/CD28 扩增调节性 T 细胞在移植中应用的比较分析。
Transpl Immunol. 2009 Dec;22(1-2):82-92. doi: 10.1016/j.trim.2009.07.004. Epub 2009 Jul 25.
6
Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.在符合细胞治疗药品生产质量管理规范的条件下生成人同种异体抗原特异性调节性T细胞。
Cell Transplant. 2015;24(12):2527-40. doi: 10.3727/096368914X683566. Epub 2014 Aug 5.
7
Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.树突状细胞通过旁分泌的方式传递 IL-2 来控制 CD4+CD25+Treg 细胞的抑制功能体外。
PLoS One. 2012;7(9):e43609. doi: 10.1371/journal.pone.0043609. Epub 2012 Sep 12.
8
Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells.骨髓来源的树突状细胞对CD4+ CD25+ Foxp3+ T细胞的扩增作用。
Immunology. 2009 May;127(1):50-61. doi: 10.1111/j.1365-2567.2008.02927.x.
9
Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.由抗CD200R2衍生的树突状细胞刺激的胸腺细胞/脾细胞来源的CD4+CD25+调节性T细胞抑制混合淋巴细胞培养和皮肤移植排斥反应。
Transplantation. 2006 Apr 15;81(7):1027-34. doi: 10.1097/01.tp.0000214984.65520.50.
10
Alloantigen specific T regulatory cells in transplant tolerance.同种异体抗原特异性 T 调节细胞在移植耐受中的作用。
Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29.

引用本文的文献

1
Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients.嵌合抗HLA抗体受体工程化人调节性T细胞可抑制预致敏移植受者的同种抗原特异性B细胞。
Front Immunol. 2025 Aug 15;16:1601385. doi: 10.3389/fimmu.2025.1601385. eCollection 2025.
2
Mini-Review: Tregs as a Tool for Therapy-Obvious and Non-Obvious Challenges and Solutions.综述:调节性 T 细胞作为一种治疗工具——明显和不明显的挑战及解决方案。
Cells. 2024 Oct 11;13(20):1680. doi: 10.3390/cells13201680.
3
Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.供者调节性 T 细胞可迅速适应受者组织以控制小鼠急性移植物抗宿主病。
Nat Commun. 2024 Apr 15;15(1):3224. doi: 10.1038/s41467-024-47575-z.
4
Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective.临床过继性调节性T细胞疗法:现状、挑战与展望。
Front Cell Dev Biol. 2023 Jan 30;10:1081644. doi: 10.3389/fcell.2022.1081644. eCollection 2022.
5
A Comparison of Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells.使用同种异体刺激的B细胞或单核细胞衍生的树突状细胞对扩增的人类调节性T细胞进行的比较。
Front Immunol. 2021 Jun 18;12:679675. doi: 10.3389/fimmu.2021.679675. eCollection 2021.
6
Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1 dendritic cells, and epithelium-free areas containing Foxp3 thymic regulatory T cells.环孢素 A 选择性诱导胸腺髓质萎缩,导致成熟胸腺上皮细胞、XCR1 树突状细胞和不含 Foxp3 胸腺调节 T 细胞的上皮细胞的缺失。
Histochem Cell Biol. 2021 Aug;156(2):133-146. doi: 10.1007/s00418-021-01993-y. Epub 2021 May 16.
7
Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo.发现内脏脂肪 Treg 细胞的替代激动剂,可调节体内代谢指标。
Elife. 2020 Aug 10;9:e58463. doi: 10.7554/eLife.58463.
8
Control of T cell homeostasis and immune equilibrium by Lkb1 in dendritic cells.Lkb1 调控树突状细胞中 T 细胞稳态和免疫平衡。
Nat Commun. 2018 Dec 13;9(1):5298. doi: 10.1038/s41467-018-07545-8.
9
Treatment strategies for neuromyelitis optica.视神经脊髓炎的治疗策略
Tzu Chi Med J. 2018 Oct-Dec;30(4):204-208. doi: 10.4103/tcmj.tcmj_102_18.
10
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.未成熟树突状细胞治疗以依赖抗原和不依赖抗原的方式在非肥胖型糖尿病小鼠中提供持久的免疫调节。
J Immunol Res. 2018 Feb 14;2018:5463879. doi: 10.1155/2018/5463879. eCollection 2018.

本文引用的文献

1
Pillars Article: An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells. Nat. Immunol. 2003. 4: 337-342.专题文章:斯卡尔芬在CD4+CD25+调节性T细胞中的重要作用。《自然免疫学》。2003年。第4卷:337 - 342页。
J Immunol. 2017 Feb 1;198(3):993-998.
2
Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.支柱文章:Foxp3调控CD4+CD25+调节性T细胞的发育与功能。《自然免疫学》,2003年,第4卷,第330 - 336页。
J Immunol. 2017 Feb 1;198(3):986-992.
3
Pillars Article: Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science 2003. 299: 1057-1061.支柱文章:转录因子Foxp3对调节性T细胞发育的控制。《科学》2003年。299卷:1057 - 1061页。
J Immunol. 2017 Feb 1;198(3):981-985.
4
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.肿瘤细胞将未成熟的髓样树突状细胞转化为分泌转化生长因子β的细胞,从而诱导CD4+CD25+调节性T细胞增殖。
J Exp Med. 2005 Oct 3;202(7):919-29. doi: 10.1084/jem.20050463. Epub 2005 Sep 26.
5
Induction of regulatory properties in dendritic cells by Valpha14 NKT cells.通过Vα14自然杀伤T细胞诱导树突状细胞的调节特性。
J Immunol. 2005 Sep 15;175(6):3648-55. doi: 10.4049/jimmunol.175.6.3648.
6
Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.哈氏小体指导树突状细胞在人类胸腺中诱导产生CD4+CD25+调节性T细胞。
Nature. 2005 Aug 25;436(7054):1181-5. doi: 10.1038/nature03886.
7
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.使用双顺反子报告基因鉴定表达Foxp3的抑制性T细胞。
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5126-31. doi: 10.1073/pnas.0501701102. Epub 2005 Mar 28.
8
Natural regulatory T cells in infectious disease.传染病中的天然调节性T细胞。
Nat Immunol. 2005 Apr;6(4):353-60. doi: 10.1038/ni1181.
9
Regulatory T cell lineage specification by the forkhead transcription factor foxp3.叉头转录因子foxp3对调节性T细胞谱系的特异性调控
Immunity. 2005 Mar;22(3):329-41. doi: 10.1016/j.immuni.2005.01.016.
10
Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells.显性耐受:外周调节性T细胞产生的激活阈值。
Trends Immunol. 2005 Mar;26(3):130-5. doi: 10.1016/j.it.2004.12.007.

在混合淋巴细胞反应期间,树突状细胞对同种抗原特异性Foxp3 + CD25 + CD4 +调节性T细胞的有效扩增。

Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.

作者信息

Yamazaki Sayuri, Patel Munjal, Harper Alice, Bonito Anthony, Fukuyama Hidehiro, Pack Maggi, Tarbell Kristin V, Talmor Mia, Ravetch Jeffrey V, Inaba Kayo, Steinman Ralph M

机构信息

Laboratory of Cellular Physiology and Immunology and Chris Browne Center of Immunology and Immune Disease, The Rockefeller University, New York, NY 10021, USA.

出版信息

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2758-63. doi: 10.1073/pnas.0510606103. Epub 2006 Feb 10.

DOI:10.1073/pnas.0510606103
PMID:16473944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1413800/
Abstract

Thymic-derived CD25+ CD4+ T regulatory cells (Tregs) suppress immune responses, including transplantation. Here we evaluated the ability of dendritic cells (DCs) to expand alloantigen-specific Tregs in the mixed leukocyte reaction (MLR) that develops from polyclonal populations of T cells. The allogeneic DCs, when supplemented with IL-2 in the cultures, were much more effective than bulk spleen cells in expanding the numbers of Tregs. Likewise, DCs and not spleen cells were effective in sustaining expression of the transcription factor Foxp3 in Tregs, but neither IL-2 nor CD80/86 was required for this effect in the cultures. On a per-cell basis, the DC-expanded, but not unexpanded, Tregs were more potent suppressors of a fresh MLR by CD25- CD4+ T cells. Suppression was 3- to 10-fold more active for MLRs induced by the original alloantigens than for third-party stimulators. When DC-expanded Tregs were introduced into sublethally irradiated hosts, the T cells suppressed graft-versus-host-disease induced by CD25- CD4+ T cells. Again, suppression was more active against the same mouse strain that provided the DCs to expand the Tregs. Therefore, alloantigen-selected Tregs are more effective suppressors of responses to major transplantation antigens, and these Tregs can be expanded from a polyclonal repertoire by DCs.

摘要

胸腺来源的CD25⁺ CD4⁺ T调节细胞(Tregs)可抑制免疫反应,包括移植免疫反应。在此,我们评估了树突状细胞(DCs)在由多克隆T细胞群体引发的混合淋巴细胞反应(MLR)中扩增同种异体抗原特异性Tregs的能力。在培养物中添加IL-2时,同种异体DCs在扩增Tregs数量方面比脾细胞总体更有效。同样,DCs而非脾细胞能有效维持Tregs中转录因子Foxp3的表达,但培养物中产生此效应既不需要IL-2也不需要CD80/86。以单个细胞计,经DC扩增而非未扩增的Tregs对CD25⁻ CD4⁺ T细胞引发的新鲜MLR是更强有力的抑制细胞。对于由原始同种异体抗原诱导的MLR,其抑制活性比针对第三方刺激物的抑制活性高3至10倍。当将经DC扩增的Tregs引入亚致死剂量照射的宿主时,这些T细胞可抑制由CD25⁻ CD4⁺ T细胞诱导的移植物抗宿主病。同样,对于提供DCs以扩增Tregs的同一小鼠品系,抑制作用更强。因此,同种异体抗原选择的Tregs是对主要移植抗原反应更有效的抑制细胞,并且这些Tregs可由DCs从多克隆库中扩增得到。